Correlation Between Protagenic Therapeutics and Defence Therapeutics
Can any of the company-specific risk be diversified away by investing in both Protagenic Therapeutics and Defence Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Protagenic Therapeutics and Defence Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Protagenic Therapeutics and Defence Therapeutics, you can compare the effects of market volatilities on Protagenic Therapeutics and Defence Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Protagenic Therapeutics with a short position of Defence Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Protagenic Therapeutics and Defence Therapeutics.
Diversification Opportunities for Protagenic Therapeutics and Defence Therapeutics
0.21 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Protagenic and Defence is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding Protagenic Therapeutics and Defence Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Defence Therapeutics and Protagenic Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Protagenic Therapeutics are associated (or correlated) with Defence Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Defence Therapeutics has no effect on the direction of Protagenic Therapeutics i.e., Protagenic Therapeutics and Defence Therapeutics go up and down completely randomly.
Pair Corralation between Protagenic Therapeutics and Defence Therapeutics
Given the investment horizon of 90 days Protagenic Therapeutics is expected to generate 13.0 times more return on investment than Defence Therapeutics. However, Protagenic Therapeutics is 13.0 times more volatile than Defence Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Defence Therapeutics is currently generating about 0.0 per unit of risk. If you would invest 61.00 in Protagenic Therapeutics on September 3, 2024 and sell it today you would lose (2.00) from holding Protagenic Therapeutics or give up 3.28% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Very Weak |
Accuracy | 95.24% |
Values | Daily Returns |
Protagenic Therapeutics vs. Defence Therapeutics
Performance |
Timeline |
Protagenic Therapeutics |
Defence Therapeutics |
Protagenic Therapeutics and Defence Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Protagenic Therapeutics and Defence Therapeutics
The main advantage of trading using opposite Protagenic Therapeutics and Defence Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Protagenic Therapeutics position performs unexpectedly, Defence Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Defence Therapeutics will offset losses from the drop in Defence Therapeutics' long position.Protagenic Therapeutics vs. Sino Biopharmaceutical Ltd | Protagenic Therapeutics vs. Eledon Pharmaceuticals | Protagenic Therapeutics vs. Rezolute | Protagenic Therapeutics vs. XOMA Corporation |
Defence Therapeutics vs. Therapeutic Solutions International | Defence Therapeutics vs. Alpha Cognition | Defence Therapeutics vs. Vg Life Sciences | Defence Therapeutics vs. Adagene |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |